• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBill Ackman

Bill Ackman

Page 13 of 18
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceAckman Bids Farewell to Man Who Pushed for Disastrous Valeant Investment
By Laura LorenzettiMay 12, 2016
This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
FinanceThis Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
By Laura LorenzettiMay 10, 2016
CNBC Events - Season 2014
FinanceHedge Fund Managers Made a Whopping $13 Billion Last Year
By Lucinda ShenMay 10, 2016
Squawk Box - Season 20
FinanceBill Ackman: Valeant’s Drug Price Hikes Hurt America
By Sy MukherjeeApril 27, 2016
Valeant To Buy Bausch & Lomb For $8.7 Billion
FinanceWhy Bill Ackman and Valeant Should Suck It Up and Sell Bausch & Lomb
By Jen WiecznerApril 8, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Hints Who Valeant’s Next CEO Will Be
By Jen WiecznerApril 6, 2016
Squawk Box - Season 20
FinanceBill Ackman Is About to Get Seriously Grilled by Unhappy Investors
By ReutersApril 6, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceHere’s Why Moody’s Just Downgraded Valeant
By Jen WiecznerApril 1, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Can’t Sell Valeant Even If He Wants To
By Lucinda ShenMarch 31, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Asked for Information in Drug Pricing Probe
By ReutersMarch 24, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceThe Head of a Buffett-Linked Fund Just Resigned Over Its Huge Valeant Stake
By Sy MukherjeeMarch 24, 2016
Key Speakers At The 20th Annual Sohn Investment Conference
FinanceAckman’s Hedge Fund Now Down 25% in 2016
By Stephen GandelMarch 23, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceHere’s Why Valeant May Have Accused Its Former CFO of “Improper Conduct”
By ReutersMarch 21, 2016
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
FinanceWhat Caused Valeant’s Epic 90% Plunge
By Stephen Gandel and ReutersMarch 20, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceThis Valeant Investor Is In Even Bigger Trouble than Bill Ackman
By Jen WiecznerMarch 18, 2016
1...
  • 11
  • 12
  • 13
  • 14
  • 15
...18
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
Energy
‘Take the money and run’: Johns Hopkins economist Steve Hanke on why the UAE quit OPECplaceholder alt text
By Shawn TullyApril 29, 2026
AI
‘The cost of compute is far beyond the costs of the employees’: Nvidia executive says right now AI is more expensive than paying human workersplaceholder alt text
By Sasha RogelbergApril 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.